iShares Biotechnology ETF IBB
202.34 USD -1.38 (-0.68%)
As ofNov 20, 2026, 11:57 AM EST
202.24 Day range 205.96
159.68 52-week range 222.29
- YTD
- +19.89%
- 1 year
- +23.20%
5D -10.25 (-4.79%)
- Assets
- $11.41B
- Expense ratio
- 0.44%
- NAV
- 218.14
- Holdings
- 243
- Top 10 weight
- 51.4%
- Asset class
- Equity
- Issuer
- IShares
- Inception
- Feb 5, 2001
- Dividend yield
- 0.16%
- YTD return
- +19.89%
- 1-year return
- +23.20%
- Volume
- 1.23M
- Avg volume
- 1.75M
- Open
- 203.50
- Previous close
- 203.72
- Day's range
- 202.24 – 205.96
- 52-week range
- 159.68 – 222.29
- 50-day average
- 208.86
- 200-day average
- 187.32
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
News
7,518 iShares Biotechnology ETF $IBB Shares Sold by Fifth Third Bancorp Oracle Launches Life Sciences AI Agents To Work On Clinical Trial Operations
Biotech ETFs Brace for FDA Showdown: Two Drug Decisions Could Test Investor Sentiment
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
Your note
Sign in to keep a note on IBB — it syncs with the Stock Master app.
